AN2 Therapeutics (ANTX) Return on Equity [ROE] (2022 - 2026)
AN2 Therapeutics' Return on Equity [ROE] was -46.01% in Q2 2026, up 6.57 percentage points from -52.58% a year earlier and up 5.25 percentage points from the prior quarter.
Powered by 
Analysis
AN2 Therapeutics (ANTX) Return on Equity [ROE] (2022 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at AN2 Therapeutics came in at -52.15%, down 2.45 percentage points from FY2024.
- Return on Equity [ROE] shows a three-year change of +118.45 percentage points (FY2022 to FY2025).
- In earlier years, Return on Equity [ROE] was -49.69% in FY2024 (+9.17 pp), -58.87% in FY2023 (+111.73 pp) and -170.60% in FY2022.
- The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] since Q4 2022.
- Compared with a year earlier, Return on Equity [ROE] was higher in five of the last eight quarters, with an average year-over-year change of +2.63 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q1 2023 (a gain of 24.32 percentage points); the worst was Q2 2023 (a drop of 37.65 percentage points).
- Per Business Quant data, ANTX's Return on Equity [ROE] in the three quarters before Q2 2026 was -51.26% (Q1 2026), -62.02% (Q4 2025) and -52.60% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | AN2 Therapeutics | 193.16 Mn | 193.16 Mn | - | -46.01% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -46.01% |
| Mar 31, 2026 | -51.26% |
| Dec 31, 2025 | -62.02% |
| Sep 30, 2025 | -52.60% |
| Jun 30, 2025 | -52.58% |
| Mar 31, 2025 | -58.45% |
| Dec 31, 2024 | -60.55% |
| Sep 30, 2024 | -67.32% |
| Jun 30, 2024 | -65.13% |
| Mar 31, 2024 | -59.68% |
| Dec 31, 2023 | -52.82% |
| Sep 30, 2023 | -55.28% |
| Jun 30, 2023 | -65.53% |
| Mar 31, 2023 | -55.42% |
| Dec 31, 2022 | -40.72% |
| Sep 30, 2022 | -33.09% |
| Jun 30, 2022 | -27.88% |
| Mar 31, 2022 | -79.75% |
API Access
AN2 Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ANTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ANTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ANTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();